Insulin Types for Beginners: What You Need to Know

Understanding Insulin: A Comprehensive Guide for Beginners

Insulin is an essential hormone that helps your body turn food into energy and manages your blood sugar levels. For people living with diabetes, understanding insulin therapy is crucial for maintaining optimal health and preventing complications. Commercially available insulins are categorized as rapid-acting, short-acting, intermediate-acting, and long-acting. This comprehensive guide will walk you through everything you need to know about insulin types, how they work, and how to use them effectively in managing diabetes.

What Is Insulin and Why Is It Important?

Insulin is a naturally occurring hormone your pancreas makes that's essential for allowing your body to use sugar (glucose) for energy. When you eat, carbohydrates from your food are broken down into glucose and other sugars. Insulin lowers blood sugar by allowing it to move from the bloodstream into muscle, fat, and other cells, where it can be stored or used as fuel.

People with diabetes have high blood sugar because their body does not make enough insulin or because their body does not respond to insulin properly. In people with type 1 diabetes the pancreas produces little to no insulin. In people with type 2 diabetes the fat, liver, and muscle cells do not respond correctly to insulin. This is why insulin therapy becomes necessary for many people with diabetes.

The Four Main Categories of Insulin

The onset, peak, and duration of effect vary among insulin preparations. Understanding these differences is essential for effective diabetes management. Each type of insulin is designed to work at different speeds and for different durations, allowing healthcare providers to create personalized treatment plans that match individual needs and lifestyles.

Rapid-Acting Insulin: Fast and Effective

Rapid-acting insulin starts working about 15 minutes after injection, peaks (or is at maximum effectiveness) in about 1 hour and continues to work for 2 to 4 hours after injection. Examples include insulin lispro, (brand names: Admelog, Humalog), lispro-aabc (brand name: Lyumjev), insulin aspart (brand names: Fiasp, NovoLog), and insulin glulisine (brand name: Apidra).

Rapid-acting insulin is injected before a meal to prevent your blood glucose from rising, and to correct high blood sugars. This type of insulin is particularly useful for managing post-meal blood sugar spikes, which are common challenges for people with diabetes. It is taken right before or just after meals and snacks. It is often used with longer-acting insulin.

Some resources further divide them into very rapid acting with an onset between 15 to 20 minutes from injection and rapid acting with an onset of action between 15 to 30 minutes. In this list, Fiasp and Lyumjev are considered very rapid-acting insulins. These newer formulations provide even faster action, giving users more flexibility in timing their doses around meals.

Short-Acting Insulin: Regular Insulin

Regular or short-acting insulin starts working 30 minutes after injection, peaks anywhere from 2 to 3 hours after injection, and continues to work for about 3 to 6 hours. Examples include regular insulin (brand names: Humulin R, Novolin R). Short-acting insulin is also known as regular insulin and has been used for decades in diabetes management.

Regular insulin has a delayed onset of action of 30-60 minutes, and should be injected approximately 30 minutes before the meal to blunt the postprandial rise in blood glucose. This timing requirement is important for optimal effectiveness. Regular or short-acting insulin starts working within 30 minutes, peaks within 2 to 3 hours, and lasts 3 to 6 hours. This is taken a half-hour before meals and snacks.

The mechanism behind regular insulin's delayed action is fascinating. It forms hexamers after injection into the SQ space slowing its absorption. Hexameric insulin progressively dissociates into absorbable insulin dimers and monomers. This molecular process explains why regular insulin takes longer to start working compared to rapid-acting analogs.

Intermediate-Acting Insulin: NPH Insulin

Intermediate-acting insulin starts working 2 to 4 hours after injection, peaks about 4 to 12 hours later, and lasts approximately 12 to 18 hours. Examples include NPH insulin (brand names: Humulin N, Novolin N). NPH stands for Neutral Protamine Hagedorn, named after the scientists who developed it.

NPH (Neutral Protamine Hagedorn) insulin, was created in 1936 after it was discovered that the effects of subcutaneously injected insulin could be prolonged by the addition of the protein protamine. This historical development represented a major breakthrough in diabetes treatment, allowing for longer-lasting insulin coverage.

NPH insulin is an intermediate-acting insulin, with an onset of action of approximately 2 hours, peak effect 6-14 hours, and duration of action 10-16 hours (depending on the size of the dose). Because of its broad peak and long duration of action, NPH can serve as a basal insulin only when dosed at bedtime, or a basal and prandial insulin when dosed in the morning.

Intermediate-acting insulin starts working within 2 to 4 hours, peaks in 4 to 12 hours, and lasts 12 to 18 hours. This is taken mostly either twice a day or once at bedtime. The flexibility in dosing schedules makes NPH insulin a practical option for many people with diabetes, though it requires careful timing to avoid hypoglycemia during peak action periods.

Long-Acting Insulin: Basal Coverage

Long-acting insulin is most often combined with rapid- or short-acting insulin. It starts working several hours after injection and tends to lower glucose levels up to 24 hours or almost a full day. Long-acting insulins provide steady, consistent insulin levels throughout the day and night, mimicking the basal insulin secretion of a healthy pancreas.

Long-acting insulin starts to work within a few hours and works for about 24 hours, sometimes longer. It helps control glucose throughout the day. It is often combined with rapid- or short-acting insulin as needed. Common brand names include Lantus, Basaglar, Toujeo, Levemir, and Tresiba.

Ultra long-acting insulin starts working in 6 hours, but it does not peak and lasts about 36 hours, and in some cases longer than that. These ultra-long-acting formulations represent the newest generation of basal insulins, offering even more stable blood sugar control with less frequent dosing requirements.

The newest ultralong-acting basal insulin formulations (glargine U300, degludec U100, and U200) have more prolonged and stable pharmacokinetic and pharmacodynamic characteristics than glargine U100 and detemir. These advanced formulations provide more predictable insulin action with reduced risk of hypoglycemia, particularly overnight.

Special Insulin Formulations

Premixed or Combination Insulin

Combination Insulin/Pre-Mixed/Fixed Combination: This type of insulin combines different types of insulin into 1 injection. It starts working within 5 to 60 minutes. The peaks vary and the duration is anywhere from 10 to 24 hours. Examples include the brand names: Humalog Mix 75/25, Humalog Mix 50/50, NovoLog Mix 70/30, and Novolin 70/30.

Mixed insulin products are various combinations of short-acting or rapid-acting insulin and intermediate-acting insulin to provide both basal and bolus coverage in the same injection. Benefits include minimizing injection burden and simplifying insulin regimens. This can be particularly helpful for people who have difficulty managing multiple injections or who prefer a simpler routine.

However, premixed insulins have some limitations. Mixed insulin products may not allow for flexibility if frequent mealtime coverage is needed. The fixed ratios mean you cannot adjust the basal and bolus components independently, which may be necessary when meal sizes or activity levels vary significantly.

Inhaled Insulin: A Needle-Free Option

In 2014, the FDA approved an inhalable insulin formulation. It passes through the lungs and into the bloodstream and provides a rapid onset of action within 12 minutes. It can be taken by patients with diabetes type 1 and type 2 before meals. This rapid acting inhaled insulin, known by the brand name Afrezza, is a human insulin inhaled power form of regular human insulin.

In 2015 an inhaled insulin product, Afrezza, became available in the U.S. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal and can be used by adults with type 1 or type 2 diabetes. Afrezza is not a substitute for long-acting insulin. Afrezza must be used in combination with injectable long-acting insulin in patients with type 1 diabetes and in type 2 patients who use long-acting insulin.

Inhaled insulin offers an alternative for people who are needle-averse or who want more convenience at mealtimes. However, it requires regular lung function monitoring and is not suitable for everyone, particularly those with lung conditions like asthma or chronic obstructive pulmonary disease.

Concentrated Insulin Formulations

Insulin also comes in different concentrations. The concentration of insulin identifies the number of units of insulin in 1 milliliter (mL). The most commonly used concentration in the United States is U-100. The higher concentrations are used to decrease the volume of injection needed to administer an insulin dosage and are used when larger amounts of insulin are required for glucose management.

Regular U-500 insulin has delayed onset and a longer duration of action; it functions similarly to an intermediate-acting (NPH) insulin and can be used as 2 or 3 daily injections. U-500 insulin is five times more concentrated than standard U-100 insulin, making it useful for people with severe insulin resistance who require very high doses.

Understanding Insulin Therapy Regimens

Basal and Bolus Insulin Concepts

Basal dose - provides a steady amount of insulin delivered all day and night. This helps maintain blood glucose levels by controlling how much glucose the liver releases (mainly at night when the time between meals is longer). Basal insulin mimics the low-level, continuous insulin secretion that occurs in people without diabetes.

Bolus dose - provides a dose of insulin at meals to help move absorbed sugar from the blood into muscle and fat. Bolus doses can also help correct blood sugar when it gets too high. Bolus doses are also called nutritional or meal-time doses. This two-component approach to insulin therapy more closely mimics natural insulin secretion patterns.

Basal-Bolus Therapy

Basal-bolus therapy is widely regarded as one of the most effective strategies for diabetes management and blood sugar control. This approach divides insulin into two components: basal insulin, which accounts for about 40–50% of the total daily dose, and bolus insulin, which covers meals and corrections, making up the remaining 50–60%.

The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook notes 0.5 units/kg/day as a typical starting dose in adults with type 1 diabetes who are metabolically stable, with approximately one-half administered as prandial insulin given to manage blood glucose after meals and the remaining portion as basal insulin to manage glycemia in the periods between meal absorption.

According to the American Diabetes Association (ADA), basal-bolus regimens closely mimic natural insulin secretion and are highly effective in lowering A1C and improving glucose variability. Carbohydrate counting is central to this method, with insulin-to-carb ratios such as 1:10 to 1:15 allowing precise dosing based on food intake, while insulin sensitivity factors help correct high readings.

Type 1 Diabetes Insulin Requirements

Insulin is the primary treatment in all patients with type 1 diabetes mellitus (T1DM). Typically, patients with T1DM will require initiation with multiple daily injections at the time of diagnosis. People with type 1 diabetes require lifelong insulin therapy because their pancreas produces little to no insulin.

In adults newly diagnosed with type 1 diabetes, insulin requirements at initiation typically range from 0.2 to 0.6 units/kg/day, with lower doses often sufficient in those with continued endogenous insulin production (during the partial remission phase or "honeymoon" period, or in people presenting outside of ketoacidosis). These requirements can change over time as the disease progresses.

Type 2 Diabetes and Insulin

People with type 2 diabetes need to take insulin when other treatments and medicines fail to control blood sugar levels. Many people with type 2 diabetes can initially manage their condition with lifestyle modifications and oral medications, but insulin therapy may become necessary as the disease progresses.

Patients with type 2 diabetes mellitus (T2DM) who are on insulin can typically be treated initially with basal insulin with prandial insulin added if control remains suboptimal. This stepwise approach allows for gradual intensification of therapy as needed to achieve blood sugar targets.

Insulin Delivery Methods

Insulin administration can be via subcutaneous, intravenous, and intramuscular routes. The route of administration usually depends on the patient's condition and setting. The subcutaneous route is the most widespread route of administration and is preferred by most patients due to its ease and convenience in administration.

Syringes and Vials

Insulin syringe -- insulin is drawn from a vial into a syringe. Using the needle, you inject the insulin under the skin. This traditional method has been used for decades and remains a cost-effective option for many people. Syringes come in different sizes to accommodate various insulin doses.

Injections may be given in the abdomen, outer thigh, back of the arm, and flank/buttocks region. Rotating injection sites is important to prevent lipohypertrophy, a condition where fatty lumps develop under the skin that can affect insulin absorption.

Insulin Pens

Insulin pens have become increasingly popular due to their convenience and ease of use. Benefits of insulin pens include the convenience of storing at room temperature for 28 days after opening and ease of use compared to traditional vials and syringes. Pens are more portable, discreet, and often more accurate for dosing.

The shortest needles (currently the 4-mm pen and 6-mm syringe needles) are safe, effective, and less painful and should be the first-line choice in all patient categories. Modern pen needles are much thinner and shorter than older needles, making injections more comfortable.

Insulin Pumps

The insulin pump is a device that works like a natural pancreas. It replaces the need for long-acting insulin and continuously delivers small amounts of short-acting insulin to the body throughout the day. Insulin pumps offer the most precise insulin delivery and greatest flexibility in dosing.

Insulin pumps deliver continuous subcutaneous insulin infusion with precise basal rates as low as 0.025 units per hour, offering greater flexibility than injections. This level of precision allows for fine-tuning of insulin delivery to match individual needs throughout the day and night.

Pumps often lead to improved outcomes, including A1C reductions of 0.5–1% and increased time-in-range by 10–15%, while also reducing severe hypoglycemia through automated features like insulin suspension. Modern pumps can automatically suspend insulin delivery when blood sugar levels drop too low, providing an important safety feature.

Automated Insulin Delivery Systems

AID systems, which integrate CSII via an insulin pump, a CGM, and a control algorithm to adjust insulin delivery in real time based on glucose levels, are safe and effective for people with type 1 diabetes. Randomized controlled trials (RCTs) and real-world studies have demonstrated the ability of commercially available systems to improve achievement of glycemic goals while reducing the risk of hypoglycemia.

These systems represent the cutting edge of diabetes technology, often referred to as "artificial pancreas" systems. They continuously monitor blood sugar levels and automatically adjust insulin delivery, reducing the burden of diabetes management and improving outcomes.

Insulin Storage and Handling

Proper insulin storage is essential for maintaining its effectiveness. Unopened insulin vials, pens, and cartridges should be stored in the refrigerator at temperatures between 36°F and 46°F (2°C to 8°C). Never freeze insulin, as freezing destroys its effectiveness. If insulin has been frozen, it should be discarded.

Once opened, most insulin can be kept at room temperature for 28 days, though some formulations may have different requirements. Always check the package insert for specific storage instructions for your particular insulin product. Keep insulin away from direct heat and sunlight, as extreme temperatures can degrade the medication.

Before each injection, inspect your insulin. It should be clear and colorless (except for NPH and premixed insulins, which should appear uniformly cloudy after gentle mixing). If you notice any discoloration, clumping, or particles in clear insulin, do not use it. NPH and premixed insulins should be gently rolled between your hands to mix them before use—never shake vigorously.

Potential Side Effects and Complications

Hypoglycemia

Hypoglycemia is, by far, the most common adverse effect of insulin therapy. Low blood sugar can occur when insulin doses are too high, meals are skipped or delayed, or physical activity is increased without adjusting insulin doses. Symptoms of hypoglycemia include shakiness, sweating, confusion, rapid heartbeat, dizziness, and hunger.

However, intensive therapy was associated with a higher rate of severe hypoglycemia than conventional treatment (62 compared with 19 episodes per 100 person-years of therapy). This finding from the landmark DCCT trial highlighted the importance of balancing tight blood sugar control with the risk of hypoglycemia.

Mild hypoglycemia can usually be treated by consuming 15-20 grams of fast-acting carbohydrates, such as glucose tablets, fruit juice, or regular soda. Severe hypoglycemia, where the person is unable to treat themselves, requires emergency treatment with glucagon injection or emergency medical services.

Weight Gain

The other adverse effects of insulin therapy include weight gain and rarely electrolyte disturbances like hypokalemia, especially when used along with other drugs causing hypokalemia. Weight gain occurs because insulin promotes glucose storage and can increase appetite. This side effect can be managed through careful attention to diet, portion control, and regular physical activity.

Metformin combined with insulin is associated with decreased weight gain, lower insulin dose, and less hypoglycemia when compared with insulin alone. For people with type 2 diabetes, continuing metformin when starting insulin therapy can help minimize weight gain and improve overall outcomes.

Injection Site Reactions

Lipohypertrophy is a common complication where repeated injections in the same area cause fatty lumps to develop under the skin. These lumps can affect insulin absorption, leading to unpredictable blood sugar levels. Rotating injection sites and avoiding injecting into areas with lipohypertrophy is essential for consistent insulin absorption.

Other injection site reactions may include redness, swelling, or itching. These are usually mild and resolve on their own. If you experience persistent or severe injection site reactions, consult your healthcare provider.

Monitoring Blood Sugar Levels

Regular blood sugar monitoring is essential when using insulin therapy. Whether you're newly diagnosed or refining your routine, insulin therapy can help maintain fasting glucose between 70–130 mg/dL and post-meal levels within 80–180 mg/dL. These targets reduce complications and improve long-term health outcomes.

Traditional blood glucose meters require finger-stick testing, which provides a snapshot of blood sugar at a specific moment. The frequency of testing depends on your insulin regimen and individual needs. People using multiple daily injections or insulin pumps typically need to test at least four times daily: before meals and at bedtime.

Continuous Glucose Monitoring

Continuous glucose monitoring improves blood sugar control by providing real-time data and trend insights. It helps individuals respond quickly to changes and reduce the risk of both high and low glucose levels. CGM systems use a small sensor inserted under the skin to measure glucose levels continuously throughout the day and night.

Devices like Dexcom G7 and Freestyle Libre 3 provide continuous readings and alerts when glucose levels move outside target ranges, helping prevent dangerous fluctuations. Calibration-free sensors can last up to 14 days, giving users a clearer and more consistent view of daily glucose patterns.

When combined with insulin types used in pump or MDI therapy, CGM supports hybrid closed-loop systems that automatically adjust insulin delivery. This integration of technologies represents a major advancement in diabetes care, reducing the burden of constant decision-making about insulin doses.

Working with Your Healthcare Team

Be sure to check the dosing information that comes with your insulin and follow your doctor's instructions. For more information about types of insulin and when to take them, talk to your doctor or diabetes educator. Your healthcare team is your most valuable resource in managing diabetes effectively.

Your health care provider will work with you to find the right combination of medicines for you. Insulin therapy is highly individualized, and what works for one person may not be ideal for another. Factors such as lifestyle, meal patterns, activity levels, other medications, and personal preferences all play a role in determining the best insulin regimen.

Understanding the utility of different insulin products is difficult for both providers and patients. As a result, we aim to provide a concise mini-review of insulin products and their use with the intention to provide a guide to clinicians on how to navigate various insulin products and their use, as well as reviewing key clinical situations.

Insulin Dosing and Adjustment

Your provider can calculate the insulin dose for you and teach you how to do the calculation. Your provider will also tell you how and when to check your blood sugar and time your doses during the day and night. Learning to adjust your insulin doses based on blood sugar readings, carbohydrate intake, and activity levels is an important skill for effective diabetes management.

Fasting plasma glucose (FPG) values should be used to titrate basal insulin, whereas both FPG and postprandial glucose (PPG) values should be used to titrate mealtime insulin. This approach ensures that both background and mealtime insulin needs are adequately addressed.

Adjust one insulin at a time. Begin with the insulin that will correct the first problem blood glucose of the day. This systematic approach to insulin adjustment helps identify which insulin needs modification and prevents making too many changes at once, which can make it difficult to determine what's working.

Overcoming Barriers to Insulin Therapy

Many people experience psychological resistance to starting insulin therapy. Common concerns include fear of needles, worry about weight gain, anxiety about hypoglycemia, and the misconception that needing insulin means they have failed to manage their diabetes properly. These concerns are normal and should be discussed openly with your healthcare provider.

Modern insulin delivery devices have made insulin therapy much more convenient and less painful than in the past. Pen needles are extremely thin and short, and many people report that injections are much less uncomfortable than they anticipated. Insulin pens are discreet and portable, making it easier to take insulin when away from home.

Education and support are crucial for successful insulin therapy. Diabetes educators can provide hands-on training in insulin injection techniques, blood sugar monitoring, and carbohydrate counting. Support groups, whether in-person or online, can connect you with others who understand the challenges of living with diabetes and using insulin.

Special Considerations

Insulin During Illness

When you're sick, your blood sugar levels can become unpredictable. Illness and infection cause stress hormones to be released, which can raise blood sugar levels even if you're eating less than usual. Never stop taking insulin when you're sick, even if you're not eating normally. Your healthcare provider can give you specific guidelines for adjusting insulin doses during illness.

Monitor your blood sugar more frequently when you're ill, and test for ketones if your blood sugar is consistently above 240 mg/dL. Contact your healthcare provider if you're unable to keep food or fluids down, if you have persistent high blood sugar, or if you have moderate to large ketones.

Exercise and Physical Activity

Physical activity affects blood sugar levels and insulin requirements. Exercise makes your body more sensitive to insulin and can lower blood sugar levels for up to 24 hours after activity. This means you may need to reduce insulin doses or eat extra carbohydrates before, during, or after exercise to prevent hypoglycemia.

The effect of exercise on blood sugar depends on the type, intensity, and duration of activity, as well as your blood sugar level when you start exercising. Work with your healthcare team to develop a plan for adjusting insulin and carbohydrate intake around physical activity. Always carry fast-acting carbohydrates with you when exercising in case your blood sugar drops too low.

Traveling with Insulin

When traveling, always carry insulin and supplies in your carry-on luggage, never in checked baggage where it could freeze or be lost. Bring more insulin and supplies than you think you'll need in case of delays or unexpected situations. Keep insulin in its original packaging with the pharmacy label to avoid problems at security checkpoints.

If traveling across time zones, work with your healthcare provider before your trip to develop a plan for adjusting insulin timing. Bring a letter from your doctor explaining your need for insulin and diabetes supplies, especially if traveling internationally. Consider wearing medical identification jewelry that indicates you have diabetes and use insulin.

The Future of Insulin Therapy

Insulin therapy continues to evolve with new technologies and formulations. Once-weekly insulin icodec (Awiqli®) is approved in multiple countries (EU, Canada, Japan, Australia) but is not FDA-approved in the U.S. at this time. Weekly insulin formulations could dramatically reduce injection burden for people with diabetes.

Biosimilar insulins are becoming more available, offering lower-cost alternatives to brand-name insulins. Insulin glargine-yfgn (Semglee®) and glargine-aglr (Rezvoglar®) are FDA-designated interchangeable with Lantus®. These biosimilars have the same safety and effectiveness as the original products but at potentially lower costs.

Research continues into new insulin delivery methods, including oral insulin formulations, insulin patches, and improved automated insulin delivery systems. Smart insulin pens that track doses and timing are already available, helping people better manage their insulin therapy and share data with their healthcare providers.

Key Takeaways for Insulin Beginners

Understanding insulin types and how they work is fundamental to effective diabetes management. Each type of insulin has specific characteristics regarding onset, peak, and duration of action. Rapid-acting insulins work quickly to cover meals, short-acting insulins provide mealtime coverage with slightly longer action, intermediate-acting insulins bridge longer periods, and long-acting insulins provide steady background coverage.

Since insulin action times can vary by individual, the onset, peak and duration times are only guidelines. As you and those you work with know well, so many things in diabetes including insulin action time can feel more like an art than an exact science. This variability emphasizes the importance of regular blood sugar monitoring and working closely with your healthcare team.

Different brands of insulin vary in onset, peak time, and duration, even if they're the same type, such as rapid acting. Always follow the specific instructions for your particular insulin product and don't switch brands or types without consulting your healthcare provider.

Summary: Quick Reference Guide

• Rapid-Acting Insulin: Starts working in 15 minutes, peaks in 1 hour, lasts 2-4 hours. Used before meals. Examples: Humalog, NovoLog, Apidra, Fiasp, Lyumjev.
• Short-Acting Insulin: Starts working in 30 minutes, peaks in 2-3 hours, lasts 3-6 hours. Taken 30 minutes before meals. Examples: Humulin R, Novolin R.
• Intermediate-Acting Insulin: Starts working in 2-4 hours, peaks in 4-12 hours, lasts 12-18 hours. Provides basal coverage. Examples: Humulin N, Novolin N (NPH).
• Long-Acting Insulin: Starts working in a few hours, lasts 24+ hours, provides steady basal coverage. Examples: Lantus, Basaglar, Levemir, Toujeo, Tresiba.
• Premixed Insulin: Combines rapid/short-acting with intermediate-acting insulin in fixed ratios. Simplifies regimens but reduces flexibility.
• Inhaled Insulin: Rapid-acting, needle-free option for mealtime coverage. Must be combined with long-acting insulin. Brand name: Afrezza.

Additional Resources

For more information about insulin therapy and diabetes management, consider these trusted resources:

• American Diabetes Association (https://diabetes.org) - Comprehensive diabetes information, including detailed insulin guides and support resources
• JDRF (Juvenile Diabetes Research Foundation) (https://www.jdrf.org) - Focused on type 1 diabetes research and support
• Centers for Disease Control and Prevention Diabetes Resources (https://www.cdc.gov/diabetes) - Evidence-based diabetes information and statistics
• Association of Diabetes Care & Education Specialists (https://www.adces.org) - Find certified diabetes educators and educational resources
• Cleveland Clinic Diabetes Resources (https://my.clevelandclinic.org) - Patient education materials and expert guidance

Remember that insulin therapy is a powerful tool for managing diabetes and preventing complications. While it may seem overwhelming at first, with education, practice, and support from your healthcare team, using insulin can become a routine part of your daily life. Don't hesitate to ask questions, seek support, and advocate for your needs as you navigate your diabetes management journey.